Sort   by:  
 Page size 
UnknownBacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating <i>GNLY</i> <sup>+</sup>CD8<sup>+</sup> T cells.
Not available
S-EPMC12505032 | biostudies-literature
UnknownHepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy.
Not available
S-EPMC12014897 | biostudies-literature
UnknownRice Genomics: over the Past Two Decades and into the Future.
Not available
S-EPMC6411948 | biostudies-literature
UnknownCompositional Variability and Mutation Spectra of Monophyletic SARS-CoV-2 Clades.
Not available
S-EPMC7875716 | biostudies-literature
UnknownIntestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Not available
S-EPMC11774752 | biostudies-literature
UnknownAuthor Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Not available
S-EPMC11774751 | biostudies-literature
UnknownPersonalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer.
Not available
S-EPMC11293329 | biostudies-literature
UnknownGut-liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice.
Not available
S-EPMC11726454 | biostudies-literature
Sort   by:  
 Page size